Estradiol sustained release from high affinity cyclodextrin hydrogels

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 66, Issue 1, 2007, Pages 55-62

  Rodriguez Tenreiro, C ^a   Alvarez Lorenzo, C ^a   Rodriguez Perez, A ^a   Concheiro, A ^a   Torres Labandeira, J J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chemically cross linked hydrogels; Controlled release; Hydrophobic drugs; Hydroxypropyl cyclodextrin; Inclusion complexes; Methyl cyclodextrin; Sulfobutyl cyclodextrin

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CRYSMEB; CYCLODEXTRIN; ESTRADIOL; ETHYLENE GLYCOL; KLEPTOSE; METHYL BETA CYCLODEXTRIN; METHYLCELLULOSE; UNCLASSIFIED DRUG;

ARTICLE; AUTOCLAVE; CROSS LINKING; DRUG RELEASE; DRUG SOLUBILITY; HYDROGEL; HYDROPHOBICITY; PARTITION COEFFICIENT; SUSPENSION; SUSTAINED RELEASE FORMULATION; SWELLING;

BETA-CYCLODEXTRINS; CROSS-LINKING REAGENTS; CYCLODEXTRINS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EPOXY RESINS; ESTRADIOL; HYDROGELS; HYDROPHOBICITY; METHYLCELLULOSE; SOLUBILITY; TIME FACTORS;

EID: 33947133150     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.09.003     Document Type: Article

References (37)

1. Woolfson A.D., Malcolm R.K., and Gallagher R. Drug delivery by the intravaginal route. Crit. Rev. Ther. Drug 17 (2000) 509-555
2. Fraser I.S., and Mansour D. Delivery systems for hormone replacement therapy. Expert Opin. Drug Deliv. 3 (2006) 191-204
3. Sweerman S.C. Martindale: The Complete Drug Reference. 33rd ed. (2002), Pharmaceutical Press, London
4. Kuhl H. Pharmacology of estrogens and progestagens: influence of different routes of administration. Climateric 8 (2005) 3-63
5. Johnson M.E., Blankschtein D., and Langer R. Permeation of steroids through human skin. J. Pharm. Sci. 84 (1995) 1144-1146
6. Sheu M.T., Chen S.Y., Chen L.C., and Ho H.O. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. J. Control. Rel. 88 (2003) 355-368
7. Monti D., Najarro M., Chetoni R., Burgalassi S., Saettone M.F., and Boldrini E. Vehicle and enhancer effects on transdermal permeation of estradiol from gel formulations: evaluation in vitro. J. Drug Deliv. Sci. Technol. 15 (2005) 469-473
8. Kitano M., Maitani Y., Takayama N., and Nagai T. Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17 β-estradiol from hydrogels containing three types of absorption enhancers. Int. J. Pharm. 174 (1998) 19-28
9. Dezarnaulds G., and Fraser I.S. Vaginal ring delivery of hormone replacement therapy - a review. Expert Opin. Pharmacother. 4 (2003) 201-212
10. Barreiro-Iglesias R., Alvarez-Lorenzo C., and Concheiro A. Controlled release of estradiol solubilized in carbopol/surfactant aggregates. J. Control. Rel. 93 (2003) 319-330
11. Peltola S., Saarinen-Savolainen P., Kiesvaara J., Suhonen T.M., and Urtti A. Microemulsions for topical delivery of estradiol. Int. J. Pharm. 254 (2003) 99-107
12. Lehman L., Simes S., and Simon J.A. Bio-E-Gel(TM), a transdermal estradiol gel formulation for the treatment of postmenopausal vasomotor symptoms. Menopause 12 (2005) 814
13. Peppas N.A., Wood K.M., and Blanchette J.O. Hydrogels for oral delivery of therapeutic proteins. Expert Opin. Biol. Ther. 4 (2004) 881-887
14. DiRamio J.A., Kisaalita W.S., Majetich G.F., and Shimkus J.M. Poly(ethylene glycol) methacrylate/dimethacrylate hydrogels for controlled release of hydrophobic drugs. Biotechnol. Prog. 21 (2005) 1281-1288
15. Bromberg L., Temchenko M., and Hatton T.A. Smart microgel studies. Polyelectrolyte and drug-absorbing properties of microgels from polyether-modified poly(acrylic acid). Langmuir 19 (2003) 8675-8684
16. Liu Y.Y., Fan X.D., Hu H., and Tang Z.H. Release of chlorambucil from poly(N-isopropylacrylamide) hydrogels with β-cyclodextrin moieties. Macromol. Biosci. 4 (2004) 729-736
17. Liu YY., Fan XD., Kang T., and Sun L. A cyclodextrin microgel for controlled release driven by inclusion effects. Macromol. Rapid Commun. 25 (2004) 1912-1916
18. Kanjickal D., Lopina S., Evancho-Chapman M.M., Schmidt S., and Donovan D. Improving delivery of hydrophobic drugs from hydrogels through cyclodextrins. J. Biomed. Mater. Res. 74A (2005) 454-460
19. Uekama K. Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull. 52 (2004) 900-915
20. Liu Y.Y., Fan X.D., and Zhao Y.B. Synthesis and characterization of a poly(N-isopropylacrylamide) with β-cyclodextrin as pendant groups. J. Polym. Sci. A Polym. Chem. 43 (2005) 3516-3524
21. Stella V., and Rajewski R.A. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14 (1997) 556-567
22. Stella V.J., Rao V.M., Zannou E.A., and Zia V. Mechanisms of drug release from cyclodextrin complexes. Adv. Drug Deliv. Rev. 36 (1999) 3-16
23. Uekama K., Hirayama F., and Irie T. Application of cyclodextrins in pharmaceutical preparations. Drug Target. Deliv. 3 (1994) 411-456
24. Siemoneit U., Schmitt C., Alvarez-Lorenzo C., Luzardo A., Otero-Espinar F., Concheiro A., and Blanco-Mendez J. Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability. Int. J. Pharm. 312 (2006) 66-74
25. Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Rodriguez-Perez A., Concheiro A., and Torres-Labandeira J.J. New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability. Pharm. Res. 23 (2006) 121-130
26. Loftsson T., and Bodor N. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17-beta-estradiol. Acta Pharm. Nord. 1 (1989) 185-194
27. Fridriksdottir H., Loftsson T., Gudmundsson J.A., Bjarnason G.J., Kjeld M., and Thorsteinsson T. Design and in vivo testing of 17 beta-estradiol-HPbetaCD sublingual tablets. Pharmazie 51 (1996) 39-42
28. Deng Y.J., and Huang M.J. Capillary electrophoretic separation and theoretical study of inclusion complexes of sulfobutyl ether beta-cyclodextrin with estrogens. Int. J. Quantum Chem. 100 (2004) 746-752
29. Werner U., Damge C., Maincent P., and Bodmeier R. Properties of in situ gelling nasal inserts containing estradiol/methyl beta-cyclodextrin. J. Drug Deliv. Sci. Technol. 14 (2004) 275-284
30. Higuchi T., and Connors K.A. Phase-solubility techniques. In: Reilly C.N. (Ed). Advances in Analytical Chemistry and Instrumentation vol. 4 (1965), Wiley-Interscience, New York 117-212
31. Loftsson T., Hreinsdóttir D., and Másson M. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302 (2005) 18-28
32. Gehrke S.H., Biren D., and Hopkins J.J. Evidence for Fickian water transport in initially glassy poly(2-hydroxyethyl methacrylate). J. Biomater. Sci. Polymer Edn. 6 (1994) 375-390
33. Higuchi W.I. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51 (1962) 802-804
34. Nishijo J., Morjyama S., Shiota S., Kamigauchi M., and Sugiura M. Interaction of heptakis (2,3,6-tri-O-methyl)-beta-cyclodextrin with cholesterol in aqueous solution. Chem. Pharm. Bull. 52 (2004) 1405-1410
35. Piel G., Piette M., Barillaro V., Castagne D., Evrard B., and Delattre L. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics. Int. J. Pharm. 312 (2006) 75-82
36. Loftsson T., Másson M., and Sigurjónsdóttir J.F. Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma Sci. 9 (1999) 237-242
37. Kim S.W., Bae Y.H., and Okano T. Hydrogels: swelling, drug loading and release. Pharm. Res. 9 (1992) 283-290